For the millions of Americans who are born with or develop heart disease, stem cell research offers the first hope of reversing or repairing heart muscle damage. Thus, early reports…
California's Stem Cell Agency (CIRM) has catalyzed the growth of stem cell research by helping recruit scientists to the state. In this video, we feature Dr. Todd McDevitt, a leading biomedical…
Watch this Google Hangout to learn about recent progress in developing stem cell therapies for heart disease. Hear from stem cell clinical trial participant Fred Lesikar, stem cell experts Dr.…
Title: Lessons learned from Phase 1 trial of heart-derived stem cells as we move into Phase 2 Speaker: Eduardo Marbán, M.D., Ph.D. Founder and Chairman of Scientific Advisory Board, Capricor,…
One percent of live births have heart defects, the leading noninfectious cause of death in the 1st year. Using embryonic stem cell technology, Dr. Deepak Srivastava's lab has made many…
Long-term stem cell-based strategies for heart disease aim to rebuild parts of the heart. But investigators like Deepak Srivastava are also looking into more near term goals to regenerate heart…
The day before 9/11, just four months pregnant, Mary Goulart and her husband learned through ultrasounds that their baby had several heart defects including a missing left ventricle. After birth,…
CIRM has funded a $5.5 million Disease Team to develop a follow-on cardiac stem cell clinical trial that uses a patient's own heart stem cells to regenerate scarred tissue damaged…
Robert Klein, J.D. and Claire Pomeroy, M.D., M.B.A., gave the welcoming remarks for the "Spotlight on Cardiovascular Therapies," an educational event presented at the California Institute for Regenerative Medicine Governing…
